CALUMET INC (CLMT) Stock Analyst Ratings
NASDAQ:CLMT - Nasdaq - US1314281049 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to CLMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.67. This target is 85.31% above the current price.
CLMT was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CLMT.
In the previous month the buy percentage consensus was at a similar level.
CLMT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | UBS | Downgrade | Neutral -> Sell |
| 2025-01-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-11 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-17 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | TD Cowen | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-12-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-10-31 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-13 | Goldman Sachs | Maintains | Buy |
| 2023-05-15 | UBS | Maintains | Neutral -> Neutral |
| 2023-05-08 | TD Cowen | Maintains | Outperform |
| 2023-05-08 | Wells Fargo | Maintains | Overweight |
| 2023-01-25 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-14 | UBS | Initiate | Neutral |
| 2022-08-18 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2022-06-28 | Cowen & Co. | Maintains | Outperform |
| 2022-05-09 | Cowen & Co. | Maintains | Outperform |
| 2022-04-21 | Wells Fargo | Maintains | Overweight |
| 2022-02-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-23 | Wolfe Research | Upgrade | Peer Perform -> Outperform |